Upper gastrointestinal bleeding guidelines for management

Revision as of 19:24, 13 October 2017 by Usama Talib (talk | contribs)
Jump to navigation Jump to search

Upper gastrointestinal bleeding Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Upper Gastrointestinal Bleeding from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Management

Initial resuscitation
Pharmacotherapy
Risk stratification

Surgery

Surgical Management
Endoscopic Intervention

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Guidelines for Management

Case Studies

Case #1

Upper gastrointestinal bleeding guidelines for management On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Upper gastrointestinal bleeding guidelines for management

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Upper gastrointestinal bleeding guidelines for management

CDC on Upper gastrointestinal bleeding guidelines for management

Upper gastrointestinal bleeding guidelines for management in the news

Blogs on Upper gastrointestinal bleeding guidelines for management

Directions to Hospitals Treating Upper gastrointestinal bleeding

Risk calculators and risk factors for Upper gastrointestinal bleeding guidelines for management

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

NAME OF GUIDELINE(DO NOT EDIT)

Class I
"1. (Level of Evidence: )"

NAME OF GUIDELINE (DO NOT EDIT)[1]

Class I
"1.(Level of Evidence: )"
"2.(Level of Evidence: )"
"3. (Level of Evidence:)"
Class IIa
"1. .(Level of Evidence: )"
"2. (Level of Evidence: )"
"3. (Level of Evidence: )"
"4. (Level of Evidence: )"

References

  1. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, Hiratzka LF, Murphy WR, Olin JW, Puschett JB, Rosenfield KA, Sacks D, Stanley JC, Taylor LM, White CJ, White J, White RA, Antman EM, Smith SC, Adams CD, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Hunt SA, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B (2006). "ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation". Circulation. 113 (11): e463–654. doi:10.1161/CIRCULATIONAHA.106.174526. PMID 16549646. Retrieved 2012-10-09. Unknown parameter |month= ignored (help)


Template:WikiDoc Sources